The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Hospitals & Providers Strategy
From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
Willis Towers Watson research finds a dramatic increase among employers seeking to differentiate their health and well-being programs for competitive advantage.
With influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
Trump’s new proposal would broaden access to association health plans. Here’s six things to know.
As the opioid epidemic rages, doctors and hospitals should consider these tips and strategies employed by other organizations.
More awareness and new state laws regarding end-of-life treatment are affecting treatment approaches. Here’s what you need to know.